NCT06597851

Insulin Resistance and Coronary Microvascular Dysfunction in Patients With Myocardial Ischemia and Non-obstructive Coronary Artery Disease

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2024-06-24Est. Completion: 2026-10-30

Enrollment target: 40 participants

Locations

Azienda Ospedaliera Universitaria di Verona, Verona, VR, Italy

Other microbiome trials you might be interested in

Effect of Trimetazidine on Coronary Flow in Transthyretin Cardiac AmyloidosisPhase 2Recruiting

Transthyretin Cardiac Amyloidosis

The goal of this clinical trial is to learn if trimetazidine can improve blood flow in the heart in adults with transthy…

São Paulo, BrazilEst. completion Aug 1, 2027

View Trial →

The DISCOVER INOCA Prospective Multi-center RegistryRecruiting

Ischemia and No Obstructive Coronary Artery DiseaseCoronary Microvascular DysfunctionCoronary VasospasmEndothelial DysfunctionMicrovascular AnginaChest Pain With Normal Coronary Angiography

The overall objective of this multi-center registry is to identify specific phenotypes of INOCA with both an anatomic ev…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.